
Oncologist Faculty Burnout Caused by “Unrealistic” Expectations, Says ASCO CEO
About this episode
“An increasingly unrealistic set of performance expectations” is putting a strain on oncologist faculty members, says Clifford Hudis, MD, CEO of the American Society of Clinical Oncology (ASCO). He discussed the mounting challenges for academic cancer physicians and how ASCO is working to address them with Robert A. Figlin, MD, the interim director of Cedars-Sinai Cancer in Los Angeles and Steven Spielberg Family Chair in Hematology-Oncology. Dr. Hudis explained that academic oncologists are expected to be clinicians, researchers, teachers, and administrators. “And in most cases, there just isn’t a pay line and salary support for all four of those jobs, nor are there enough hours in the week for somebody to do all four of those jobs in a superb way,” he said. When it comes to ASCO’s ability to enable proactive change, Dr. Hudis explains that “we don’t have an enforcement mechanism. All we can do is shine a very bright light on reality and then ask for collective action to identify best approaches.”
Dr. Hudis reported no relevant financial relationships.
Dr. Figlin reported various financial relationships.
Get every episode summarized
Each time Oncology News Central Peer-Spectives publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Oncology News Central Peer-Spectives

Tackling “the Biggest Question That Everyone Is Asking” in Breast Cancer Care
Oncology News Central Peer-Spectives

Shared Decision Making and Toxicity Management in EGFR- Mutated Advanced NSCLC
Oncology News Central Peer-Spectives

“Where the Real Answer Lies”: How CNS Disease Influences EGFR-Mutated NSCLC Trea...
Oncology News Central Peer-Spectives

“Is the Juice Worth the Squeeze?”: Treatment Intensification for Advanced EGFRm...
Oncology News Central Peer-Spectives